← Back to Search

Behavioral Intervention

Peer Navigator Training for HIV Prevention in Hispanic/Latino Men

N/A
Waitlist Available
Led By Scott D Rhodes, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be ≥18 years of age
Report identifying as male and having had sex with at least 1 man in the past 6 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to post-intervention up to 18 months
Awards & highlights

Study Summary

This trial aims to reduce HIV infection in Hispanic/Latino men who have sex with men. We must address disparities among vulnerable groups.

Who is the study for?
This trial is for Hispanic/Latino men, aged 18 or older, living in Mecklenburg County, NC who identify as gay or bisexual and have had sex with a man in the past 6 months. Participants must speak English and Spanish and provide informed consent.Check my eligibility
What is being tested?
The study tests whether training peer navigators can help reduce HIV disparities among Hispanic/Latino men who have sex with men. Some participants will receive this intervention later to compare outcomes.See study design
What are the potential side effects?
Since the intervention involves training rather than medication, traditional physical side effects are not expected; however, there may be emotional or social impacts from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am a man who has had sexual relations with another man in the last 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to post-intervention up to 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to post-intervention up to 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Rate of Human Immunodeficiency Virus (HIV) testing
Change in Rate of medical mistrust
Change in Rate of pre-exposure prophylaxis (PrEP) uptake
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: delayed-intervention groupExperimental Treatment1 Intervention
Training is designed to increase knowledge and skills. The delayed-intervention group will be trained in year 5
Group II: Navigators (peer navigator) trainingExperimental Treatment1 Intervention
Training is designed to increase knowledge and skills. Navigators in the intervention group will be trained and supported for 12 months of implementation across years 3 and 4

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,242 Previous Clinical Trials
1,004,123 Total Patients Enrolled
Scott D Rhodes, PhDPrincipal InvestigatorWake Forest University Health Sciences
4 Previous Clinical Trials
758 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining opportunities to participate in this clinical trial?

"Data hosted on clinicaltrials.gov shows that recruitment for this trial has ended as of November 14th 2023; however, there are currently 621 other trials actively seeking patients."

Answered by AI
~96 spots leftby Aug 2028